07:00 , May 17, 2010 |  BC Week In Review  |  Financial News

N30 Pharma completes venture financing

N30 Pharma LLC , Boulder, Colo.   Business: Pulmonary, Inflammation   Date completed: 5/11/10   Type: Venture financing   Raised: $10 million   Investors: Deerfield Management; Bridger Capital; Swift Current; individual investor  ...
00:25 , May 12, 2010 |  BC Extra  |  Financial News

N30 raises $10 million

N30 Pharma LLC (Boulder, Colo.) raised $10 million in a venture round led by new investor Deerfield Management. Existing investors Bridger Capital, Swift Current and an individual investor also participated. N30's lead compound, N6022, is...
07:00 , Sep 18, 2000 |  BC Extra  |  Financial News

Point Biomedical raises $17.3 million

Point Biomedical (San Carlos, Calif.) raised $17.3 million in a venture financing. Investors included CHL Medical Partners; De Novo Ventures; Frazier; Institutional Venture Partners; Medicus Ventures; Sprout Group; Bollard Group; Bridger Capital; Mosaix Ventures; Narrangansett...